Panbela Therapeutics Inc.

05/06/2024 | Press release | Distributed by Public on 05/06/2024 06:16

Panbela Announces Issuance of New Patent in the US and Canada; Patent is for Claims of a Fixed Dose Combination of Eflornithine and Sulindac

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.